The DOI matches its Crossref record; 275 of the 275 references it cites were found in a registry or an index.
Structural insights into the functional diversity of the CDK–cyclin family
Open accessAbstract
Since their characterization as conserved modules that regulate progression through the eukaryotic cell cycle, cyclin-dependent protein kinases (CDKs) in higher eukaryotic cells are now also emerging as significant regulators of transcription, metabolism and cell differentiation. The cyclins, though originally characterized as CDK partners, also have CDK-independent roles that include the regulation of DNA damage repair and transcriptional programmes that direct cell differentiation, apoptosis and metabolic flux. This review compares the structures of the members of the CDK and cyclin families determined by X-ray crystallography, and considers what mechanistic insights they provide to guide functional studies and distinguish CDK- and cyclin-specific activities. Aberrant CDK activity is a hallmark of a number of diseases, and structural studies can provide important insights to identify novel routes to therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–275 of 275
Distinct Activation Pathways Confer Cyclin-Binding Specificity on Cdk1 and Cdk2 in Human Cells
Merrick, K. A., Larochelle, S., Zhang, C., Allen, J. J., Shokat, K. M., & Fisher, R. P. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.10.022 · Cited by 100
Bao, Z., Jacobsen, D. M., & Young, M. A. (2011) · Structure · doi:10.1016/j.str.2011.02.016 · Cited by 99
The Role of the Phospho-CDK2/Cyclin A Recruitment Site in Substrate Recognition
Cheng, K. Y., Noble, M. E. M., Skamnaki, V., Brown, N. R., Lowe, E. D., Kontogiannis, L., Shen, K., Cole, P. A., Siligardi, G., & Johnson, L. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600480200 · Cited by 94
Cyclin-Dependent Kinases as Coregulators of Inflammatory Gene Expression
Schmitz, M. L., & Kracht, M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.10.004 · Cited by 94
Suzuki, K., Sako, K., Akiyama, K., Isoda, M., Senoo, C., Nakajo, N., & Sagata, N. (2015) · Scientific Reports · doi:10.1038/srep07929 · Cited by 93
Interaction between Cdc37 and Cdk4 in human cells
Lamphere, L., Fiore, F., Xu, X., Brizuela, L., Keezer, S. M., Sardet, C., Draetta, G. F., & Gyuris, J. (1997) · Oncogene · doi:10.1038/sj.onc.1201036 · Cited by 92
Development of a Potent, Specific CDK8 Kinase Inhibitor Which Phenocopies CDK8/19 Knockout Cells
Koehler, M. F. T., Bergeron, P., Blackwood, E. M., Bowman, K. K., Clark, K., Firestein, R., Kiefer, J. R., Maskos, K., McCleland, M. L., Orren, L., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00278 · Cited by 90
Venkataramani, R. N., Swaminathan, K., & Marmorstein, R. (1998) · Nature Structural Biology · doi:10.1038/nsb0198-74 · Cited by 89
Cell-specific responses to loss of cyclin-dependent kinases
Berthet, C., & Kaldis, P. (2007) · Oncogene · doi:10.1038/sj.onc.1210243 · Cited by 89
CDK10/cyclin M is a protein kinase that controls ETS2 degradation and is deficient in STAR syndrome
Guen, V. J., Gamble, C., Flajolet, M., Unger, S., Thollet, A., Ferandin, Y., Superti‐Furga, A., Cohen, P. A., Meijer, L., & Colas, P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306814110 · Cited by 89
Millar, E. K. A., Dean, J. L., McNeil, C. M., O’Toole, S. A., Henshall, S. M., Tran, T. H., Lin, J., Quong, A. A., Comstock, C. E. S., Witkiewicz, A. K., et al. (2009) · Oncogene · doi:10.1038/onc.2009.13 · Cited by 88
Lu, H., Li, Z., Xue, Y., Schulze‐Gahmen, U., Johnson, J. R., Krogan, N. J., Alber, T., & Zhou, Q. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318503111 · Cited by 87
Keramisanou, D., Aboalroub, A. A., Zhang, Z., Liu, W., Marshall, D., Diviney, A., Larsen, R. W., Landgraf, R., & Gelis, I. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.04.005 · Cited by 87
Cyclin A2 is an RNA binding protein that controls Mre11 mRNA translation
Kanakkanthara, A., Jeganathan, K. B., Limzerwala, J. F., Baker, D. J., Hamada, M., Nam, H.-J., van Deursen, W. H., Hamada, N., Naylor, R. M., Becker, N. A., et al. (2016) · Science · doi:10.1126/science.aaf7463 · Cited by 87
The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat
Schulze‐Gahmen, U., Upton, H. E., Birnberg, A., Bao, K., Chou, S., Krogan, N. J., Zhou, Q., & Alber, T. (2013) · eLife · doi:10.7554/elife.00327 · Cited by 86
Specificity of cyclin D1 for androgen receptor regulation.
Petre, C. E., Cook, S. L., Burd, C. J., Marshall, T. W., Wetherill, Y. B., & Knudsen, K. E. (2003) · PubMed · Cited by 84
CDKS and CKIS: Molecular targets for tissue remodelling
Nabel, E. G. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd869 · Cited by 83
Conformational processing of oncogenic v-Src kinase by the molecular chaperone Hsp90
Boczek, E. E., Reefschläger, L. G., Dehling, M., Struller, T. J., Häusler, E., Seidl, A., Kaila, V. R. I., & Büchner, J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424342112 · Cited by 82
Garthe, A., Huang, Z., Kaczmarek, L., Filipkowski, R. K., & Kempermann, G. (2014) · Genes Brain & Behavior · doi:10.1111/gbb.12130 · Cited by 82
Brd4 and HEXIM1: Multiple Roles in P-TEFb Regulation and Cancer
Chen, R., Yik, J. H. N., Lew, Q. J., & Chao, S. (2014) · BioMed Research International · doi:10.1155/2014/232870 · Cited by 81
Cyclin K regulates prereplicative complex assembly to promote mammalian cell proliferation
Lei, T., Zhang, P., Zhang, X., Xiao, X., Zhang, J., Qiu, T., Dai, Q., Zhang, Y., Min, L., Li, Q., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04258-w · Cited by 81
Greenblatt, M. S., Beaudet, J. G., Gump, J., Godin, K. S., Trombley, L. M., Koh, J., & Bond, J. P. (2003) · Oncogene · doi:10.1038/sj.onc.1206101 · Cited by 76
CDK6 inhibits white to beige fat transition by suppressing RUNX1
Hou, X. S., Zhang, Y., Li, W., Hu, A. J., Luo, C., Zhou, W., Hu, J. K., Daniele, S. G., Wang, J., Sheng, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03451-1 · Cited by 76
Three-dimensional structure of human cyclin H, a positive regulator of the CDK-activating kinase
Kim, K. K., Chamberlin, H. M., Morgan, D. O., & Kim, S. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb1096-849 · Cited by 75
Members of the Undiagnosed Diseases Network, Bostwick, B. L., McLean, S., Posey, J. E., Streff, H. E., Gripp, K. W., Blesson, A., Powell‐Hamilton, N., Tusi, J., Stevenson, D. A., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0463-8 · Cited by 74
Geisen, C., & Möröy, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205919200 · Cited by 73
Essential role of the Cdk2 activator RingoA in meiotic telomere tethering to the nuclear envelope
Mikolčević, P., Isoda, M., Shibuya, H., Barrantes, I. D. B., Igea, A., Suja, J. A., Shackleton, S., Watanabe, Y., & Nebreda, Á. R. (2016) · Nature Communications · doi:10.1038/ncomms11084 · Cited by 72
Structural basis for CDK6 activation by a virus-encoded cyclin
Schulze‐Gahmen, U., & Kim, S. (2002) · Nature Structural Biology · doi:10.1038/nsb756 · Cited by 70
Tu, Z., Bayazit, M. B., Liu, H., Zhang, J., Busayavalasa, K., Risal, S., Shao, J., Ande, S., Coppola, V., Tessarollo, L., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618465114 · Cited by 69
Evidence for a protein domain superfamily shared by the cyclins, TFIIB and RB/p107
Gibson, T. J., Thompson, J., Blocker, A., & Kouzarides, T. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.6.946 · Cited by 66
CDK11 in TREX/THOC Regulates HIV mRNA 3′ End Processing
Pak, V., Eifler, T., Jäger, S., Krogan, N. J., Fujinaga, K., & Peterlin, B. M. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.10.012 · Cited by 66
Differential Regulation of G1 CDK Complexes by the Hsp90-Cdc37 Chaperone System
Hallett, S. T., Pastok, M. W., Morgan, R. M. L., Wittner, A., Blundell, K. L. I. M., Felletár, I., Wedge, S. R., Prodromou, C., Noble, M. E. M., Pearl, L. H., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.042 · Cited by 66
Self-citationUnmasking the Redundancy Between Cdk1 and Cdk2 at G2 Phase in Human Cancer Cell Lines
L’Italien, L., Tanudji, M., Russell, L., & Schebye, X. M. (2006) · Cell Cycle · doi:10.4161/cc.5.9.2721 · Cited by 65
Design and Development of a Series of Potent and Selective Type II Inhibitors of CDK8
Bergeron, P., Koehler, M. F. T., Blackwood, E. M., Bowman, K. K., Clark, K., Firestein, R., Kiefer, J. R., Maskos, K., McCleland, M. L., Orren, L., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00044 · Cited by 65
Eisfeld, A.-K., Kohlschmidt, J., Schwind, S., Nicolet, D., Blachly, J. S., Orwick, S. J., Shah, C., Bainazar, M. A., Kroll, K. W., Walker, C. J., et al. (2016) · Leukemia · doi:10.1038/leu.2016.332 · Cited by 63
Crystal structure of HIV-1 Tat complexed with human P-TEFb and AFF4
Gu, J., Babayeva, N. D., Suwa, Y., Baranovskiy, A. G., Price, D. H., & Tahirov, T. H. (2014) · Cell Cycle · doi:10.4161/cc.28756 · Cited by 62
Díaz-Martínez, L. A., Tian, W., Li, B., Warrington, R. T., Jia, L., Brautigam, C. A., Luo, X., & Yu, H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.616490 · Cited by 62
Schulze‐Gahmen, U., Lu, H., Zhou, Q., & Alber, T. (2014) · eLife · doi:10.7554/elife.02375 · Cited by 60
Pause, play, repeat: CDKs push RNAP II's buttons
Sansó, M., & Fisher, R. P. (2013) · Transcription · doi:10.4161/trns.25146 · Cited by 60
Structure of the Cyclin T binding domain of Hexim1 and molecular basis for its recognition of P-TEFb
Dames, S. A., Schönichen, A., Schulte, A., Barborič, M., Peterlin, B. M., Grzesiek, S., & Geyer, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701848104 · Cited by 60
Mikolčević, P., Rainer, J., & Geley, S. (2012) · Cell Cycle · doi:10.4161/cc.21592 · Cited by 59
Li, Y., Jin, K., Bunker, E. N., Zhang, X., Luo, X., Liu, X., & Hao, B. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708677115 · Cited by 58
CCNYL1, but Not CCNY, Cooperates with CDK16 to Regulate Spermatogenesis in Mouse
Zi, Z., Zhang, Z., Li, Q., An, W., Zeng, L., Gao, D., Yang, Y., Zhu, X., Zeng, R., Shum, W. W., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005485 · Cited by 56
Lubanska, D., Market-Velker, B. A., deCarvalho, A. C., Mikkelsen, T., da Silva, E. F., & Porter, L. A. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.006 · Cited by 55
Non-canonical roles of PFKFB3 in regulation of cell cycle through binding to CDK4
Jia, W., Zhao, X., Zhao, L., Yan, H., Li, J., Yang, H., Huang, G., & Liu, J. (2018) · Oncogene · doi:10.1038/s41388-017-0072-4 · Cited by 55
Structure and inhibitor specificity of the PCTAIRE-family kinase CDK16
Dixon-Clarke, S. E., Shehata, S. N., Krojer, T. J., Sharpe, T., von Delft, F., Sakamoto, K., & Bullock, A. N. (2017) · Biochemical Journal · doi:10.1042/bcj20160941 · Cited by 54
Structure-based discovery of cyclin-dependent protein kinase inhibitors
Martin, M. P., Endicott, J., & Noble, M. E. M. (2017) · Essays in Biochemistry · doi:10.1042/ebc20170040 · Cited by 53
Self-citationThe Cyclin-dependent Kinases cdk2 and cdk5 Act by a Random, Anticooperative Kinetic Mechanism
Clare, P. M., Poorman, R. A., Kelley, L. C., Watenpaugh, K. D., Bannow, C. A., & Leach, K. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102034200 · Cited by 52
An evolutionary conserved Hexim1 peptide binds to the Cdk9 catalytic site to inhibit P-TEFb
Kobbi, L., Demey, E., Brayé, F., Proux, F., Kolesnikova, O., Vinh, J., Poterszman, A., & Bensaude, O. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612331113 · Cited by 52
Kinase-independent function of E-type cyclins in liver cancer
Geng, Y., Michowski, W., Chick, J. M., Wang, Y. E., Jecrois, M., Sweeney, K. E., Liu, L., Han, R. C., Ke, N., Zagożdżon, A., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711477115 · Cited by 52
Lischetti, T., Zhang, G., Sedgwick, G. G., Bolaños-García, V. M., & Nilsson, J. (2014) · Nature Communications · doi:10.1038/ncomms6563 · Cited by 51
Lahti, J. M., Li, H., & Kidd, V. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10859 · Cited by 51
Baumgartner, R., Fernandez-Catalan, C., Winoto, A., Huber, R., Engh, R. A., & Holak, T. A. (1998) · Structure · doi:10.1016/s0969-2126(98)00128-2 · Cited by 51
The awakening of the CDK10/Cyclin M protein kinase
Guen, V. J., Gamble, C., Lees, J. A., & Colas, P. (2017) · Oncotarget · doi:10.18632/oncotarget.15024 · Cited by 49
P38SAPK2 phosphorylates cyclin D3 at Thr-283 and targets it for proteasomal degradation
Casanovas, O., Jaumot, M., Paules, A.-B., Agell, N., & Bachs, O. (2004) · Oncogene · doi:10.1038/sj.onc.1208040 · Cited by 47
Li, O., Ferreira, A. M., Otieno, S. B., 利民, L. X. 肖., Bashford, D., & Kriwacki, R. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.244095 · Cited by 44
Windpassinger, C., Piard, J., Bonnard, C., Alfadhel, M., Lim, S., Bisteau, X., Blouin, S., Ali, N. A., Ng, A. Y. J., Lu, H. K., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.08.003 · Cited by 44
Structural basis of divergent cyclin‐dependent kinase activation by Spy1/RINGO proteins
McGrath, D. A., Fifield, B., Marceau, A. H., Tripathi, S. M., Porter, L. A., & Rubin, S. M. (2017) · The EMBO Journal · doi:10.15252/embj.201796905 · Cited by 42
Konstantinidis, A. K., Radhakrishnan, R., Gu, F., Rao, R. N., & Yeh, W. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26506 · Cited by 41
Hormone-induced DNA damage response and repair mediated by cyclin D1 in breast and prostate cancer
Sante, G. D., Rocco, A. D., Pupo, C., Casimiro, M. C., & Pestell, R. G. (2017) · Oncotarget · doi:10.18632/oncotarget.19413 · Cited by 41
Bimodal activation of BubR1 by Bub3 sustains mitotic checkpoint signaling
Han, J. S., Vitre, B., Fachinetti, D., & Cleveland, D. W. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416277111 · Cited by 40
Targeting low molecular weight cyclin E (LMW-E) in breast cancer
Nanos-Webb, A., Jabbour, N. A., Multani, A. S., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1638-4 · Cited by 39
Dixon-Clarke, S. E., Elkins, J. M., Cheng, S.-W. G., Morin, G. B., & Bullock, A. N. (2015) · Scientific Reports · doi:10.1038/srep17122 · Cited by 38
The CDK9 Tail Determines the Reaction Pathway of Positive Transcription Elongation Factor b
Baumli, S., Hole, A. J., Wang, L.-Z., Noble, M. E. M., & Endicott, J. (2012) · Structure · doi:10.1016/j.str.2012.08.011 · Cited by 38
Self-citationBhaduri, S., Valk, E., Winters, M. J., Gruessner, B., Loog, M., & Pryciak, P. M. (2015) · Current Biology · doi:10.1016/j.cub.2014.11.069 · Cited by 37
The crystal structure of human cyclin H
Andersen, G. R., Poterszman, A., Egly, J., Moras, D., & Thierry, J. C. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01143-x · Cited by 36
Jirawatnotai, S., Sharma, S., Michowski, W., Suktitipat, B., Geng, Y., Quackenbush, J. F., Elias, J. E., Gygi, S. P., Wang, Y. E., & Siciński, P. (2014) · Cell Cycle · doi:10.4161/15384101.2014.946850 · Cited by 30
The Temporal Ordering of Cell-Cycle Phosphorylation
Kamenz, J., & Ferrell, J. E. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.01.025 · Cited by 29
Crystal Structure of Human Cyclin K, a Positive Regulator of Cyclin-dependent Kinase 9
Baek, K., Brown, R. S., Birrane, G., & Ladias, J. A. A. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.11.057 · Cited by 28
The Kinase-Independent, Second Life of CDK6 in Transcription
Otto, T., & Siciński, P. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.07.019 · Cited by 28
Cyclin D2 knockout mice with depleted adult neurogenesis learn Barnes maze task.
Urbach, A., Robakiewicz, I., Baum, E., Kaczmarek, L., Witte, O. W., & Filipkowski, R. K. (2012) · Behavioral Neuroscience · doi:10.1037/a0031222 · Cited by 25
Cyclin Y phosphorylation- and 14-3-3-binding-dependent activation of PCTAIRE-1/CDK16
Shehata, S. N., Deák, M., Morrice, N. A., Ohta, E., Hunter, R. W., Kalscheuer, V. M., & Sakamoto, K. (2015) · Biochemical Journal · doi:10.1042/bj20150486 · Cited by 22
Recurrent cyclin D2 mutations in myeloid neoplasms
Khanna, V., Eide, C. A., Tognon, C. E., Maxson, J. E., Wilmot, B., Bottomly, D., McWeeney, S. K., Edwards, D. K., V, Druker, B. J., & Tyner, J. W. (2017) · Leukemia · doi:10.1038/leu.2017.195 · Cited by 15
The LxCxE pRb Interaction Domain of Cyclin D1 Is Dispensable for Murine Development
Landis, M. W., Brown, N. E., Baker, G. L., Shifrin, A., Das, M., Geng, Y., Siciński, P., & Hinds, P. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1207 · Cited by 13
14-3-3 Binding to Cyclin Y contributes to cyclin Y/CDK14 association
Li, S., Jiang, M., Wang, W., & Chen, J. (2014) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmu005 · Cited by 11
Cited by
Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer
Klomp, J. E., Diehl, J. N., Klomp, J. A., Edwards, A. C., Yang, R., Morales, A. J., Taylor, K. E., Drizyte-Miller, K., Bryant, K. L., Schaefer, A., et al. (2024) · Science · doi:10.1126/science.adk0850 · Cited by 83
Metadata
- Authors
- Wood, D. J., & Endicott, J. A.
- Venue
- Open Biology
- Publisher
- The Royal Society
- Published
- 2018-09
- Volume
- 8
- Issue
- 9
- ISSN
- 2046-2441 (ISSN-L)
- OpenAlex
- W2892322996
- Cited by
- 260
- References
- 275
- FWCI
- 6.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.